<?xml version="1.0" encoding="utf-8"?>
<root>
  <!-- 
    Microsoft ResX Schema 
    
    Version 2.0
    
    The primary goals of this format is to allow a simple XML format 
    that is mostly human readable. The generation and parsing of the 
    various data types are done through the TypeConverter classes 
    associated with the data types.
    
    Example:
    
    ... ado.net/XML headers & schema ...
    <resheader name="resmimetype">text/microsoft-resx</resheader>
    <resheader name="version">2.0</resheader>
    <resheader name="reader">System.Resources.ResXResourceReader, System.Windows.Forms, ...</resheader>
    <resheader name="writer">System.Resources.ResXResourceWriter, System.Windows.Forms, ...</resheader>
    <data name="Name1"><value>this is my long string</value><comment>this is a comment</comment></data>
    <data name="Color1" type="System.Drawing.Color, System.Drawing">Blue</data>
    <data name="Bitmap1" mimetype="application/x-microsoft.net.object.binary.base64">
        <value>[base64 mime encoded serialized .NET Framework object]</value>
    </data>
    <data name="Icon1" type="System.Drawing.Icon, System.Drawing" mimetype="application/x-microsoft.net.object.bytearray.base64">
        <value>[base64 mime encoded string representing a byte array form of the .NET Framework object]</value>
        <comment>This is a comment</comment>
    </data>
                
    There are any number of "resheader" rows that contain simple 
    name/value pairs.
    
    Each data row contains a name, and value. The row also contains a 
    type or mimetype. Type corresponds to a .NET class that support 
    text/value conversion through the TypeConverter architecture. 
    Classes that don't support this are serialized and stored with the 
    mimetype set.
    
    The mimetype is used for serialized objects, and tells the 
    ResXResourceReader how to depersist the object. This is currently not 
    extensible. For a given mimetype the value must be set accordingly:
    
    Note - application/x-microsoft.net.object.binary.base64 is the format 
    that the ResXResourceWriter will generate, however the reader can 
    read any of the formats listed below.
    
    mimetype: application/x-microsoft.net.object.binary.base64
    value   : The object must be serialized with 
            : System.Runtime.Serialization.Formatters.Binary.BinaryFormatter
            : and then encoded with base64 encoding.
    
    mimetype: application/x-microsoft.net.object.soap.base64
    value   : The object must be serialized with 
            : System.Runtime.Serialization.Formatters.Soap.SoapFormatter
            : and then encoded with base64 encoding.

    mimetype: application/x-microsoft.net.object.bytearray.base64
    value   : The object must be serialized into a byte array 
            : using a System.ComponentModel.TypeConverter
            : and then encoded with base64 encoding.
    -->
  <xsd:schema id="root" xmlns="" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:msdata="urn:schemas-microsoft-com:xml-msdata">
    <xsd:import namespace="http://www.w3.org/XML/1998/namespace" />
    <xsd:element name="root" msdata:IsDataSet="true">
      <xsd:complexType>
        <xsd:choice maxOccurs="unbounded">
          <xsd:element name="metadata">
            <xsd:complexType>
              <xsd:sequence>
                <xsd:element name="value" type="xsd:string" minOccurs="0" />
              </xsd:sequence>
              <xsd:attribute name="name" use="required" type="xsd:string" />
              <xsd:attribute name="type" type="xsd:string" />
              <xsd:attribute name="mimetype" type="xsd:string" />
              <xsd:attribute ref="xml:space" />
            </xsd:complexType>
          </xsd:element>
          <xsd:element name="assembly">
            <xsd:complexType>
              <xsd:attribute name="alias" type="xsd:string" />
              <xsd:attribute name="name" type="xsd:string" />
            </xsd:complexType>
          </xsd:element>
          <xsd:element name="data">
            <xsd:complexType>
              <xsd:sequence>
                <xsd:element name="value" type="xsd:string" minOccurs="0" msdata:Ordinal="1" />
                <xsd:element name="comment" type="xsd:string" minOccurs="0" msdata:Ordinal="2" />
              </xsd:sequence>
              <xsd:attribute name="name" type="xsd:string" use="required" msdata:Ordinal="1" />
              <xsd:attribute name="type" type="xsd:string" msdata:Ordinal="3" />
              <xsd:attribute name="mimetype" type="xsd:string" msdata:Ordinal="4" />
              <xsd:attribute ref="xml:space" />
            </xsd:complexType>
          </xsd:element>
          <xsd:element name="resheader">
            <xsd:complexType>
              <xsd:sequence>
                <xsd:element name="value" type="xsd:string" minOccurs="0" msdata:Ordinal="1" />
              </xsd:sequence>
              <xsd:attribute name="name" type="xsd:string" use="required" />
            </xsd:complexType>
          </xsd:element>
        </xsd:choice>
      </xsd:complexType>
    </xsd:element>
  </xsd:schema>
  <resheader name="resmimetype">
    <value>text/microsoft-resx</value>
  </resheader>
  <resheader name="version">
    <value>2.0</value>
  </resheader>
  <resheader name="reader">
    <value>System.Resources.ResXResourceReader, System.Windows.Forms, Version=4.0.0.0, Culture=neutral, PublicKeyToken=b77a5c561934e089</value>
  </resheader>
  <resheader name="writer">
    <value>System.Resources.ResXResourceWriter, System.Windows.Forms, Version=4.0.0.0, Culture=neutral, PublicKeyToken=b77a5c561934e089</value>
  </resheader>
  <metadata name="sqlDataSource1.TrayLocation" type="System.Drawing.Point, System.Drawing, Version=4.0.0.0, Culture=neutral, PublicKeyToken=b03f5f7f11d50a3a">
    <value>17, 17</value>
  </metadata>
  <data name="customSqlQuery1.Sql" xml:space="preserve">
    <value>select "rUGDListe"."ID", "rUGDListe"."RaporNo",
       "rUGDListe"."Tarih", "rUGDListe"."FirmaID",
       "rUGDListe"."Versiyon", "rUGDListe"."UrunEn",
       "rUGDListe"."Barkod", "rUGDListe"."Miktar",
       "rUGDListe"."Tip1", "rUGDListe"."Tip2",
       "rUGDListe"."Uygulama", "rUGDListe"."Hedef",
       "RootTedarikci"."Ad", "RootTedarikci"."Adres",
       "RootTedarikci"."Email",
       "RootTedarikci"."Telefon"
  from ("rUGDListe" "rUGDListe"
  left join "RootTedarikci" "RootTedarikci"
       on ("RootTedarikci"."ID" = "rUGDListe"."FirmaID"))
</value>
  </data>
  <data name="customSqlQuery2.Sql" xml:space="preserve">
    <value>select "rUGDDetay"."GorunumEn", "rUGDDetay"."RenkEn",
       "rUGDDetay"."KokuEn", "rUGDDetay"."pH",
       "rUGDDetay"."Kaynama", "rUGDDetay"."Erime",
       "rUGDDetay"."Yogunluk", "rUGDDetay"."SudaEn",
       "rUGDDetay"."Viskozite", "rUGDDetay2"."Mikro",
       "rUGDDetay2"."MResim",
       "rUGDDetay2"."Challenge",
       "rUGDDetay2"."CResim",
       "rUGDDetay2"."Stabilite",
       "rUGDDetay2"."SResim", "rUGDDetay"."UrunID",
       "rUGDDetay2"."StabiliteNotEn","rUGDDetay2"."MikroNotEn","rUGDDetay2"."ChallengeNotEn",
       "rUGDDetay2"."UrunID" as "rUGDDetay2_UrunID",
       "rUGDDetay2"."KullanimEn",
       "rUGDDetay2"."UyarilarEn",
       "rUGDDetay2"."Ozellikler", "rUGDDetay2"."Kutu",
       "rUGDDetay"."DigerEn"
  from ("rUGDDetay" "rUGDDetay"
  left
  join "rUGDDetay2" "rUGDDetay2"
       on ("rUGDDetay2"."UrunID" = "rUGDDetay"."UrunID"))

</value>
  </data>
  <data name="customSqlQuery3.Sql" xml:space="preserve">
    <value>select "rUGDTip"."KategoriEn", "rUGDTip"."UrunTipiEn",
       "rUGDTip"."YuzeyAlani",
       "rUGDTip"."UygulamaBolgesiEn",
       "rUGDTip"."SiklikEn", "rUGDTip"."GunlukMiktar",
       "rUGDTip"."ADegeri", "rUGDTip"."ID"
  from "rUGDTip" "rUGDTip"
</value>
  </data>
  <data name="sqlDataSource1.ResultSchemaSerializable" xml:space="preserve">
    <value>PERhdGFTZXQgTmFtZT0ic3FsRGF0YVNvdXJjZTEiPjxWaWV3IE5hbWU9InJVR0RMaXN0ZSI+PEZpZWxkIE5hbWU9IklEIiBUeXBlPSJJbnQzMiIgLz48RmllbGQgTmFtZT0iUmFwb3JObyIgVHlwZT0iSW50MzIiIC8+PEZpZWxkIE5hbWU9IlRhcmloIiBUeXBlPSJEYXRlVGltZSIgLz48RmllbGQgTmFtZT0iRmlybWFJRCIgVHlwZT0iSW50MzIiIC8+PEZpZWxkIE5hbWU9IlZlcnNpeW9uIiBUeXBlPSJJbnQzMiIgLz48RmllbGQgTmFtZT0iVXJ1bkVuIiBUeXBlPSJTdHJpbmciIC8+PEZpZWxkIE5hbWU9IkJhcmtvZCIgVHlwZT0iU3RyaW5nIiAvPjxGaWVsZCBOYW1lPSJNaWt0YXIiIFR5cGU9IlN0cmluZyIgLz48RmllbGQgTmFtZT0iVGlwMSIgVHlwZT0iU3RyaW5nIiAvPjxGaWVsZCBOYW1lPSJUaXAyIiBUeXBlPSJTdHJpbmciIC8+PEZpZWxkIE5hbWU9IlV5Z3VsYW1hIiBUeXBlPSJTdHJpbmciIC8+PEZpZWxkIE5hbWU9IkhlZGVmIiBUeXBlPSJTdHJpbmciIC8+PEZpZWxkIE5hbWU9IkFkIiBUeXBlPSJTdHJpbmciIC8+PEZpZWxkIE5hbWU9IkFkcmVzIiBUeXBlPSJTdHJpbmciIC8+PEZpZWxkIE5hbWU9IkVtYWlsIiBUeXBlPSJTdHJpbmciIC8+PEZpZWxkIE5hbWU9IlRlbGVmb24iIFR5cGU9IlN0cmluZyIgLz48L1ZpZXc+PFZpZXcgTmFtZT0iclVHRERldGF5Ij48RmllbGQgTmFtZT0iR29ydW51bUVuIiBUeXBlPSJTdHJpbmciIC8+PEZpZWxkIE5hbWU9IlJlbmtFbiIgVHlwZT0iU3RyaW5nIiAvPjxGaWVsZCBOYW1lPSJLb2t1RW4iIFR5cGU9IlN0cmluZyIgLz48RmllbGQgTmFtZT0icEgiIFR5cGU9IlN0cmluZyIgLz48RmllbGQgTmFtZT0iS2F5bmFtYSIgVHlwZT0iU3RyaW5nIiAvPjxGaWVsZCBOYW1lPSJFcmltZSIgVHlwZT0iU3RyaW5nIiAvPjxGaWVsZCBOYW1lPSJZb2d1bmx1ayIgVHlwZT0iU3RyaW5nIiAvPjxGaWVsZCBOYW1lPSJTdWRhRW4iIFR5cGU9IlN0cmluZyIgLz48RmllbGQgTmFtZT0iVmlza296aXRlIiBUeXBlPSJTdHJpbmciIC8+PEZpZWxkIE5hbWU9Ik1pa3JvIiBUeXBlPSJCb29sZWFuIiAvPjxGaWVsZCBOYW1lPSJNUmVzaW0iIFR5cGU9IlN0cmluZyIgLz48RmllbGQgTmFtZT0iQ2hhbGxlbmdlIiBUeXBlPSJCb29sZWFuIiAvPjxGaWVsZCBOYW1lPSJDUmVzaW0iIFR5cGU9IlN0cmluZyIgLz48RmllbGQgTmFtZT0iU3RhYmlsaXRlIiBUeXBlPSJCb29sZWFuIiAvPjxGaWVsZCBOYW1lPSJTUmVzaW0iIFR5cGU9IlN0cmluZyIgLz48RmllbGQgTmFtZT0iVXJ1bklEIiBUeXBlPSJJbnQzMiIgLz48RmllbGQgTmFtZT0iU3RhYmlsaXRlTm90RW4iIFR5cGU9IlN0cmluZyIgLz48RmllbGQgTmFtZT0iTWlrcm9Ob3RFbiIgVHlwZT0iU3RyaW5nIiAvPjxGaWVsZCBOYW1lPSJDaGFsbGVuZ2VOb3RFbiIgVHlwZT0iU3RyaW5nIiAvPjxGaWVsZCBOYW1lPSJyVUdERGV0YXkyX1VydW5JRCIgVHlwZT0iSW50MzIiIC8+PEZpZWxkIE5hbWU9Ikt1bGxhbmltRW4iIFR5cGU9IlN0cmluZyIgLz48RmllbGQgTmFtZT0iVXlhcmlsYXJFbiIgVHlwZT0iU3RyaW5nIiAvPjxGaWVsZCBOYW1lPSJPemVsbGlrbGVyIiBUeXBlPSJTdHJpbmciIC8+PEZpZWxkIE5hbWU9Ikt1dHUiIFR5cGU9IlN0cmluZyIgLz48RmllbGQgTmFtZT0iRGlnZXJFbiIgVHlwZT0iU3RyaW5nIiAvPjwvVmlldz48VmlldyBOYW1lPSJyVUdEVGlwIj48RmllbGQgTmFtZT0iS2F0ZWdvcmlFbiIgVHlwZT0iU3RyaW5nIiAvPjxGaWVsZCBOYW1lPSJVcnVuVGlwaUVuIiBUeXBlPSJTdHJpbmciIC8+PEZpZWxkIE5hbWU9Ill1emV5QWxhbmkiIFR5cGU9IkludDMyIiAvPjxGaWVsZCBOYW1lPSJVeWd1bGFtYUJvbGdlc2lFbiIgVHlwZT0iU3RyaW5nIiAvPjxGaWVsZCBOYW1lPSJTaWtsaWtFbiIgVHlwZT0iU3RyaW5nIiAvPjxGaWVsZCBOYW1lPSJHdW5sdWtNaWt0YXIiIFR5cGU9IlN0cmluZyIgLz48RmllbGQgTmFtZT0iQURlZ2VyaSIgVHlwZT0iRGVjaW1hbCIgLz48RmllbGQgTmFtZT0iSUQiIFR5cGU9IkludDMyIiAvPjwvVmlldz48UmVsYXRpb24gTWFzdGVyPSJyVUdETGlzdGUiIERldGFpbD0iclVHRERldGF5Ij48S2V5Q29sdW1uIE1hc3Rlcj0iSUQiIERldGFpbD0iVXJ1bklEIiAvPjwvUmVsYXRpb24+PFJlbGF0aW9uIE1hc3Rlcj0iclVHRExpc3RlIiBEZXRhaWw9InJVR0RUaXAiPjxLZXlDb2x1bW4gTWFzdGVyPSJUaXAyIiBEZXRhaWw9IklEIiAvPjwvUmVsYXRpb24+PC9EYXRhU2V0Pg==</value>
  </data>
  <data name="xrPictureBox6.ImageSource" xml:space="preserve">
    <value>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</value>
  </data>
  <data name="xrPictureBox5.ImageSource" xml:space="preserve">
    <value>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</value>
  </data>
  <data name="xrLabel23.Text" xml:space="preserve">
    <value>A commercially available cosmetic product must be safe for human health when used under normal or foreseeable conditions of use. Stability studies were carried out on the finished product. The appearance, color, odor, pH and weight values of the product are checked at regular intervals under different temperature conditions. Stability test results are included in the product security file.</value>
  </data>
  <data name="xrLabel78.Text" xml:space="preserve">
    <value>The PAO (Period of time after opening) estimation is performed by evaluating several factors such as resistance to microbial contamination, type of packaging, duration of use (volume / dose /frequency), area of application and type of population destined for the cosmetic product. After the joint assessment of these factors, the PAO of the product can be estimated in the form of 12 months.
See Annex – Stability Test Report</value>
  </data>
  <data name="xrLabel80.Text" xml:space="preserve">
    <value>The main parameters for microbiological quality are the original level of contamination and the possibility of microbial growth. Raw materials have been evaluated based on its susceptibility to microbial growth.</value>
  </data>
  <data name="xrLabel26.Text" xml:space="preserve">
    <value>According to SCCS/1628/21, two separate categories of cosmetic products are defined in the
microbiological quality control limits:
Category 1: Products applied to children under three of age, to mucous membranes in general.
Category 2: Other products.
It is generally accepted that for cosmetics classified in Category 1, the total viable count for
aerobic mesophyllic microorganisms should not exceed 10² cfu/g or 10² cfu/ml of the product
(cfu = colony forming unit).
For cosmetics classified in Category 2, the total viable count for aerobic mesophyllic
microorganisms should not exceed 10³ cfu/g or 10³ cfu/ml of the product.
Pseudomonas aeruginosa, Staphylococcus aureus, Escherichia coli and Candida albicans are
considered the main potential pathogens in cosmetic products. These specific potential
pathogens must not be detectable in 1 g or 1 ml of a cosmetic product of Category 1 and
Category 2.
This product has to be evaluated according to Category 1.</value>
  </data>
  <data name="xrLabel24.Text" xml:space="preserve">
    <value>Microorganisms that should never be present in cosmetic products are Staphylococcus aureus, Pseudomonas aeruginosa, Candida albicans and Escherichia coli.
Since different skin areas may have different sensitivities, two separate categories have been defined for cosmetic products.</value>
  </data>
  <data name="xrLabel28.Text" xml:space="preserve">
    <value>The test involves the preparation of appropriate microorganisms at specific inoculum levels and the enumeration of microorganisms in the sample by inoculating the sample containing microorganisms at specific time intervals. The adequacy of the preservative properties of the product is determined by determining whether a significant decrease or increase in microorganisms is observed at 7, 14 and 28 days under the test conditions.</value>
  </data>
  <data name="xrLabel86.Text" xml:space="preserve">
    <value>The raw materials and mixtures in the formula were grouped according to their trade names and toxicological evaluations were made. Physical properties and toxicological profiles of raw materials and mixtures are given in Annex-3.</value>
  </data>
  <data name="xrLabel84.Text" xml:space="preserve">
    <value>Possible undesirable interactions between the product and its packaging have been evaluated. In order to predict the behaviour in medium / long term different tests were carried out at different temperatures, and it has been observed the produced effects on the packaging and the formula, in particular:
- Weight gain or loss
- Modifications of the packaging appearance
- Modifications of the formula appearance
- Packaging functionality
Possible interactions have been evaluated and the results show that the packaging is compatible with the product.
The relevant properties of the packaging material should be taken into account, as substance migration from the packaging to the formulation may occur. Information on packaging material and nominal quantity is provided in the Product Information File.</value>
  </data>
  <data name="xrTableCell12.Text" xml:space="preserve">
    <value>Sıçan, fare, tavşan veya köpeklerde yapılan 28 gün, 90 gün gibi uzun süreli tekrarlanan doz kronik toksisite, karsinojenisite, teratojenisite test çalışmalarının sonuçlarıdır. İstenmeyen etkinin gözlenmediği maddenin en yüksek uygulama miktarıdır. Tedavi veya uygulamaya bağlı olarak hiç istenmeyen etki görülmeyen en yüksek doz veya maruz kalınan madde miktarı birimi mg/kg vücut ağırlığı/gün cinsinden ifade edilir.</value>
  </data>
  <data name="xrLabel54.Text" xml:space="preserve">
    <value>According to the safety assessment report and the toxicological profile calculations, there is no obstacle in the sale of the product.
Other relevant information:
There is no claim that must be proven and there is no supporting safety data about the product.
Other documents in the Information File of the product are listed below:
a- Label 
b- Composition of product
c- GMP Certificate
d- Test results (Stability Test, Challenge and Microbiological Test)
e- SDS’es of raw materials
f- Packaging Informations
g- Production method</value>
  </data>
  <data name="xrLabel51.Text" xml:space="preserve">
    <value>A system should be established to collect, document, establish causality and manage the undesirable effects resulting from the use of the product after it is placed on the market, and when serious undesirable effects occur, the resulting from the use of the product after it is placed on the market, and when serious undesirable effects occur, the Agency should be informed in accordance with the related institute. All data on undesirable effects and serious undesirable effects related to the cosmetic product(s) should be accessible. Information on all undesirable and serious undesirable effects, including statistical data, must be included in the product information file.</value>
  </data>
  <data name="xrLabel47.Text" xml:space="preserve">
    <value>Data on the conformity control of the raw materials in the product formulation with the annexes of the Cosmetics Regulation are presented in Annex-2.
ANNEX II: LIST OF SUBSTANCES PROHIBITED IN COSMETIC PRODUCTS
ANNEX III: LIST OF SUBSTANCES WHICH COSMETIC PRODUCTS MUST NOT CONTAIN EXCEPT
SUBJECT TO THE RESTRICTIONS LAID DOWN
ANNEX IV: LIST OF COLORANTS ALLOWED IN COSMETIC PRODUCTS
ANNEX V: LIST OF PRESERVATIVES ALLOWED IN COSMETIC PRODUCTS
ANNEX VI: LIST OF UV FILTERS ALLOWED IN COSMETIC PRODUCTS</value>
  </data>
  <data name="xrLabel43.Text" xml:space="preserve">
    <value>The systemic effects and the limit of safety (MoS) are calculated on the basis of the NO(A)EL value determined on the basis of the toxicological data observed in the experiments, taking into account all significant absorption pathways. If this assessment cannot be made, the reason should be adequately justified.</value>
  </data>
  <data name="xrTableCell66.Text" xml:space="preserve">
    <value>Results of long-term repeated dose chronic toxicity, carcinogenicity, teratogenicity test studies in rats, mice, rabbits or dogs for 28 days, 90 days. The highest application amount of the substance at which no undesirable effect is observed. The highest dose or amount of exposure to which no undesirable effects are observed due to treatment or application, expressed in mg/kg body weight/day.</value>
  </data>
  <data name="xrLabel33.Text" xml:space="preserve">
    <value>The cosmetic product is manufactured according to Good Manufacturing Practice (GMP). Besides, the technical data of the product have been evaluated and heavy metals are considered technically unavoidability. According to the manufacturer’s data the product as manufactured complies with the Regulation (EC) No 1223/2009. The ingredients in the formulation do not indicate any potential interactions that may result in unintended impurities in the finished cosmetic product.</value>
  </data>
  <data name="xrLabel30.Text" xml:space="preserve">
    <value>All raw materials were assessed in terms of safety and compliance with the regulation.
Impurities are unintended substances in raw materials. A trace is a small quantity of an
unintended substance in the finished product. Impurities and traces are to be evaluated with
regard to safety of the finished product.
Unintended substances can originate from the following sources: impurities in the raw
materials/substances; the manufacturing process; potential chemical evolution/interaction
and/or migration of substances in the product that could occur under normal storage conditions and/or through contact with the packaging material.</value>
  </data>
  <data name="xrLabel58.Text" xml:space="preserve">
    <value>The calculated margin of safety for ingredients, for which toxicological data were available, found the safety factor to be acceptable (MoS &gt; ....).
In the case of components, in which no NOAEL makes impossible to calculate the margin of safety of the traditional method, it can be concluded that at the concentrations used substances do not pose a threat due to their low toxicity and a long history of safe use. These components do not show a danger to people and do not adversely affect the safety of the final cosmetic product.
The raw materials used to manufacture this product do not pose any health risk in view of their long history of use in cosmetic, pharmaceutical and food products. Based on the available toxicological data and the margins of safety calculated, the raw materials contained in the cosmetic formula do not pose a systemic toxicity risk at the concentrations used and for the intended use. There is a small possibility that the finished product may cause a slight irritation to the eyes. The accidental ingestion of a small amount of product does not pose a significant toxicological risk. In view of the method of use and the product format, no systemic risks through other exposure routes are expected under the reasonable conditions of use.
-Undesirable effects and serious undesirable effects
In the event of unintentional and serious adverse effects, corrective measures are taken and the safety assessment will be updated and added to this data file. Additional supporting safety data and evidence of claims were evaluated. There is no claim that must be proven and there is no supporting safety data about the product. GMP (Good Manufacturing Practices) is a standard that covers all production stages, from the processing of raw materials to the establishment, design, manufacture, packaging, storage and distribution of the product, in order to ensure the safe production of cosmetic products.
This product was not assessed for compliance with regulations, other than as described above, by the undersigned.
It was assumed that all ingredients assessed in the product were disclosed and are accurate as listed in the report table.
Based upon the information supplied, unless otherwise stated in this report,it was assumed that neither this product, nor the ingredients used in the product, contained any impurities/contaminants that would cause toxicity in a consumer. 
This evaluation is relevant solely to the conditions described herein.
The safety assessment was issued personally and is not transferable.</value>
  </data>
  <data name="xrRichText2.SerializableRtfString" xml:space="preserve">
    <value>{ \ r t f 1 \ d e f f 0 { \ f o n t t b l { \ f 0   C a l i b r i ; } { \ f 1 \ f c h a r s e t 1 6 2   T i m e s   N e w   R o m a n ; } { \ f 2 \ f c h a r s e t 1 6 2   F u t u r a   B k   B T ; } { \ f 3 \ f c h a r s e t 1 6 2   A r i a l ; } } { \ c o l o r t b l   ; \ r e d 0 \ g r e e n 0 \ b l u e 0   ; \ r e d 0 \ g r e e n 0 \ b l u e 2 5 5   ; } { \ * \ d e f c h p   \ f 1 \ f s 2 4 } { \ s t y l e s h e e t   { \ q l \ f 1 \ f s 2 4   N o r m a l ; } { \ * \ c s 1 \ f 1 \ f s 2 4 \ c f 1   D e f a u l t   P a r a g r a p h   F o n t ; } { \ * \ c s 2 \ s b a s e d o n 1 \ f 1 \ f s 2 4 \ c f 1   L i n e   N u m b e r ; } { \ * \ c s 3 \ u l \ f 1 \ f s 2 4 \ c f 2   H y p e r l i n k ; } { \ * \ t s 4 \ t s r o w d \ f 1 \ f s 2 4 \ q l \ t s c e l l p a d d f l 3 \ t s c e l l p a d d l 1 0 8 \ t s c e l l p a d d f b 3 \ t s c e l l p a d d f r 3 \ t s c e l l p a d d r 1 0 8 \ t s c e l l p a d d f t 3 \ t s v e r t a l t \ c l t x l r t b   N o r m a l   T a b l e ; } { \ * \ t s 5 \ t s r o w d \ s b a s e d o n 4 \ f 1 \ f s 2 4 \ q l \ t r b r d r t \ b r d r s \ b r d r w 1 0 \ t r b r d r l \ b r d r s \ b r d r w 1 0 \ t r b r d r b \ b r d r s \ b r d r w 1 0 \ t r b r d r r \ b r d r s \ b r d r w 1 0 \ t r b r d r h \ b r d r s \ b r d r w 1 0 \ t r b r d r v \ b r d r s \ b r d r w 1 0 \ t s c e l l p a d d f l 3 \ t s c e l l p a d d l 1 0 8 \ t s c e l l p a d d f r 3 \ t s c e l l p a d d r 1 0 8 \ t s v e r t a l t \ c l t x l r t b   T a b l e   S i m p l e   1 ; } } { \ * \ l i s t o v e r r i d e t a b l e } \ n o u i c o m p a t \ s p l y t w n i n e \ h t m a u t s p \ a l n t b l i n d \ e x p s h r t n \ s p l t p g p a r \ n o g r o w a u t o f i t \ p a r d \ p l a i n \ q l \ s l 2 5 8 \ s l m u l t 1 \ s a 1 6 0 { \ b \ f 2 \ f s 1 8 \ c f 0   - Q u a n t i t a t i v e   a n d   q u a l i t a t i v e   c o m p o s i t i o n   o f   t h e   c o s m e t i c   p r o d u c t . } \ b \ f 2 \ f s 1 8 \ p a r \ p a r d \ p l a i n \ q l \ s l 2 5 8 \ s l m u l t 1 \ s a 1 6 0 { \ f 2 \ f s 1 8 \ c f 0   T h e   q u a l i t a t i v e   a n d   q u a n t i t a t i v e   c o m p o s i t i o n   o f   t h e   p r o d u c t ,   i n c l u d i n g   t h e   i d e n t i f i c a t i o n   a n d   f u n c t i o n   o f   t h e   i n g r e d i e n t s   i n   t h e   c o s m e t i c   f o r m u l a ,   a s   w e l l   a s   t h e   p e r f u m e   a n a l y s i s   o f   t h e   p r o d u c t   w e r e   e v a l u a t e d .   T h e   a r o m a   u s e d   i n   t h e   p r o d u c t   c o m p l i e s   w i t h   t h e   I F R A   C o n f o r m i t y   C e r t i f i c a t e . } \ f 2 \ f s 1 8 \ p a r \ p a r d \ p l a i n \ q l \ s l 2 5 8 \ s l m u l t 1 \ s a 1 6 0 { \ b \ f 2 \ f s 1 8 \ c f 0   - P h y s i c a l / c h e m i c a l   c h a r a c t e r i s t i c s   a n d   s t a b i l i t y   o f   t h e   c o s m e t i c   p r o d u c t . } \ b \ f 2 \ f s 1 8 \ p a r \ p a r d \ p l a i n \ q l \ s l 2 5 8 \ s l m u l t 1 \ s a 1 6 0 { \ f 2 \ f s 1 8 \ c f 0   F i n a l   p r o d u c t   s p e s i f i c a t i o n s   a n d   s u p p l i e r \ u 8 2 1 7 \ ' 9 2 s   s p e s i f i c a t i o n s   f o r   e a c h   r a w   m a t e r i a l   h a v e   b e e n   r e v i e w e d . } \ f 2 \ f s 1 8 \ p a r \ p a r d \ p l a i n \ q l \ s l 2 5 8 \ s l m u l t 1 \ s a 1 6 0 { \ f 2 \ f s 1 8 \ c f 0   S t a b i l i t y   i s   e v a l u a t e d   a c c o r d i n g   t o   s t a b i l i t y   t e s t   r e p o r t   p r o v i d i n g   b y   t h e   m a n u f a c t u r e r .   S t a b i l i t y   s t u d i e s   i n d i c a t e   t h a t   t h e   p r o d u c t   r e m a i n s   s t a b l e   u n d e r   t h e   t e s t   c o n d i t i o n s .   I t   i s   d e c l a r e d   t h a t   t h e   t i m e   p e r i o d   a f t e r   o p e n i n g   i s   o f   1 2   m o n t h s   o n   t h e   l a b e l } \ f 2 \ f s 1 8 \ p a r \ p a r d \ p l a i n \ q l \ s l 2 5 8 \ s l m u l t 1 \ s a 1 6 0 { \ b \ f 2 \ f s 1 8 \ c f 0   - M i c r o b i o l o g i c a l   q u a l i t y . } \ b \ f 2 \ f s 1 8 \ p a r \ p a r d \ p l a i n \ q l \ s l 2 5 8 \ s l m u l t 1 \ s a 1 6 0 { \ f 2 \ f s 1 8 \ c f 0   T h i s   p r o d u c t   h a s   t o   b e   e v a l u a t e d   a c c o r d i n g   t o   C a t e g o r y   1 .   P r o d u c t   i s   s t a b l e   f r o m   a   m i c r o b i o l o g i c a l   p e r s p e c t i v e . } \ f 2 \ f s 1 8 \ p a r \ p a r d \ p l a i n \ q l \ s l 2 5 8 \ s l m u l t 1 \ s a 1 6 0 { \ f 2 \ f s 1 8 \ c f 0   A c c o r d i n g   t o   t h e   c h a l l e n g e   t e s t   r e s u l t s ,   t h e   m a n u f a c t u r e r   g u a r a n t e e s   t h e   e f f i c a c y   o f   t h e   p r e s e r v a t i o n   o f   t h i s   p r o d u c t   e x p e r i m e n t i a l l y   b y   c a r r y i n g   o u t   c h a l l e n g e   t e s t . } \ f 2 \ f s 1 8 \ p a r \ p a r d \ p l a i n \ q l \ s l 2 5 8 \ s l m u l t 1 \ s a 1 6 0 { \ b \ f 2 \ f s 1 8 \ c f 0   - I m p u r i t i e s ,   t r a c e s ,   i n f o r m a t i o n   a b o u t   t h e   p a c k a g i n g   m a t e r i a l . } \ b \ f 2 \ f s 1 8 \ p a r \ p a r d \ p l a i n \ q l \ s l 2 5 8 \ s l m u l t 1 \ s a 1 6 0 { \ f 2 \ f s 1 8 \ c f 0   A l l   r a w   m a t e r i a l s   w e r e   a s s e s s e d   i n   t e r m s   o f   s a f e t y   a n d   c o m p l i a n c e   w i t h   t h e   r e g u l a t i o n . } \ f 2 \ f s 1 8 \ p a r \ p a r d \ p l a i n \ q l \ s l 2 5 8 \ s l m u l t 1 \ s a 1 6 0 { \ f 2 \ f s 1 8 \ c f 0   I m p u r i t i e s   p r e s e n t   i n   t h e   i n g r e d i e n t s   a r e   w i t h i n   t h e   e s t a b l i s h e d   l i m i t s   a n d   a r e   n o t   c o n s i d e r e d   t o   b e   t o x i c o l o g i c a l l y   s i g n i f i c a n t .   Y o u   m a y   f i n d   t h e   h e a v y   m e t a l   t e s t   r e s u l t s   a s   a t t a c h e d . } \ f 2 \ f s 1 8 \ p a r \ p a r d \ p l a i n \ q l \ s l 2 5 8 \ s l m u l t 1 \ s a 1 6 0 { \ f 2 \ f s 1 8 \ c f 0   T h e   p a c k a g i n g   m a t e r i a l   a n d   i t s   p r o p e r t i e s   a r e   i n d i c a t e d .   T h i s   p a c k a g i n g   f o r m s   t h e   p r i m a r y   p a c k a g i n g   o f   t h e   p r o d u c t   t h a t   h a s   b e e n   d e s i g n e d   t o   p r e s e r v e   a n d   d i s p e n s e   t h e   c o s m e t i c   p r o d u c t   p r o p e r l y . } \ f 2 \ f s 1 8 \ p a r \ p a r d \ p l a i n \ q l \ s l 2 5 8 \ s l m u l t 1 \ s a 1 6 0 { \ f 2 \ f s 1 8 \ c f 0   P a c k a g i n g   i s   s u i t a b l y   c o m p a t i b l e   w i t h   t h e   c o s m e t i c   p r o d u c t   a n d   g u a r a n t e e s   i t s   s t a b i l i t y } \ f 2 \ f s 1 8 \ p a r \ p a r d \ p l a i n \ q l \ s l 2 5 8 \ s l m u l t 1 \ s a 1 6 0 { \ f 2 \ f s 1 8 \ c f 0   T h e   l a b e l i n g   o f   t h e   p r o d u c t   h a s   b e e n   c h e c k e d . } \ f 2 \ f s 1 8 \ p a r \ p a r d \ p l a i n \ q l \ s l 2 5 8 \ s l m u l t 1 \ s a 1 6 0 { \ f 2 \ f s 1 8 \ c f 0   P r o d u c e r \ u 8 2 1 7 \ ' 9 2 s   i n f o r m a t i o n s   h a v e   b e e n   r e v i e w e d   f o r   l a b e l l e d   w a r n i n g s &   i n s t r u c t i o n s   o f   u s e .   T h e } \ f 2 \ f s 1 8 \ p a r \ p a r d \ p l a i n \ q l \ s l 2 5 8 \ s l m u l t 1 \ s a 1 6 0 { \ f 2 \ f s 1 8 \ c f 0   i n f o r m a t i o n s   o n   t h e   l a b e l   i s   e n o u g h   f o r   t h i s   p r o d u c t . } \ f 2 \ f s 1 8 \ p a r \ p a r d \ p l a i n \ q l \ s l 2 5 8 \ s l m u l t 1 \ s a 1 6 0 { \ b \ f 2 \ f s 1 8 \ c f 0   - E x p o s u r e   t o   t h e   c o s m e t i c   p r o d u c t } \ b \ f 2 \ f s 1 8 \ p a r \ p a r d \ p l a i n \ q l \ s l 2 5 8 \ s l m u l t 1 \ s a 1 6 0 { \ f 2 \ f s 1 8 \ c f 0   A l l   i n g r e d i e n t s   s h o u l d   b e   w r i t t e n   o n   t h e   l a b e l   w i t h   t h e i r   I N C I   n a m e s   a n d   i n   d e s c e n d i n g   o r d e r   a c c o r d i n g   t o   t h e i r   p e r c e n t a g e .   I t   i s   s e e n   t h a t   t h e   p r o d u c t   l a b e l s   a r e   c o m p a t i b l e .   T h e   s p e c i f i c   e x p o s u r e   a r e a s   o n   w h i c h   t h e   p r o d u c t   w i l l   b e   a p p l i e d   a n d / o r   t o   t h e   p o p u l a t i o n   a p p r o p r i a t e   t o   i t s   a p p l i c a t i o n .   E x p o s u r e   t o   t h e   f i n i s h e d   p r o d u c t   w a s   d e t e r m i n e d   i n   a c c o r d a n c e   w i t h   t h e   r e c o m m e n d a t i o n s   o f   t h e   S C C S \ u 8 2 1 7 \ ' 9 2 s   n o t e s   o f   g u i d a n c e   f o r   t h e   t e s t i n g   o f   c o s m e t i c   s u b s t a n c e s   a n d   t h e i r   s a f e t y   e v a l u a t i o n . } \ f 2 \ f s 1 8 \ p a r \ p a r d \ p l a i n \ q l \ s l 2 5 8 \ s l m u l t 1 \ s a 1 6 0 { \ b \ f 2 \ f s 1 8 \ c f 0   - E x p o s u r e   t o   t h e   s u b s t a n c e s . } \ b \ f 2 \ f s 1 8 \ p a r \ p a r d \ p l a i n \ q l \ s l 2 5 8 \ s l m u l t 1 \ s a 1 6 0 { \ f 2 \ f s 1 8 \ c f 0   E x p o s u r e   t o   e a c h   o f   t h e   s u b s t a n c e s   i n   t h e   c o s m e t i c   p r o d u c t   i s   c a l c u l a t e d   f r o m   t h e   e x p o s u r e   t o   t h e   f i n a l   p r o d u c t   a n d   t h e   c o n c e n t r a t i o n   o f   t h e   i n d i v i d u a l   s u b s t a n c e s   i n   t h e   f i n a l   p r o d u c t .   I t   i s   n e c e s s a r y   t o   c a l c u l a t e   t h i s   e x p o s u r e   i n   o r d e r   t o   a s s e s s   t h e   p o t e n t i a l   r i s k   f r o m   e a c h   s u b s t a n c e .   E x p o s u r e   t o   i n d i v i d u a l   s u b s t a n c e s   i s   c a l c u l a t e d   f r o m   t h e   q u a n t i t a t i v e   c o m p o s i t i o n   o f   t h e   p r o d u c t .   W h e r e   s u b s t a n c e s   a r e   g e n e r a t e d   o r   r e l e a s e d   d u r i n g   t h e   u s e   o f   t h e   p r o d u c t ,   t h e   e x p o s u r e   i s   e s t i m a t e d   a n d   t a k e n   i n t o   a c c o u n t   i n   t h e   s a f e t y   a s s e s s m e n t . C a l c u l a t i o n s   w e r e   m a d e   u s i n g   t h e   f o l l o w i n g   f o r m u l a : } \ f 2 \ f s 1 8 \ p a r \ p a r d \ p l a i n \ q l \ s l 2 5 8 \ s l m u l t 1 \ s a 1 6 0 { \ f 2 \ f s 1 8 \ c f 0   D e r m a l   a b s o r p t i o n   r e p o r t e d   a s   a   p e r c e n t a g e   o f   t h e   a m o u n t   o f   s u b s t a n c e   a p p l i e d } \ f 2 \ f s 1 8 \ p a r \ p a r d \ p l a i n \ q l \ s l 2 5 8 \ s l m u l t 1 \ s a 1 6 0 { \ f 2 \ f s 1 8 \ c f 0   S E D   =   A ( m g / k g   b w / d a y )   X   C ( % )   /   1 0 0   X   D A   p   ( % )   /   1 0 0 } \ f 2 \ f s 1 8 \ p a r \ p a r d \ p l a i n \ q l \ s l 2 5 8 \ s l m u l t 1 \ s a 1 6 0 { \ f 2 \ f s 1 8 \ c f 0   P e r f o r m i n g   t h e   n e c e s s a r y   c a l c u l a t i o n s ,   a n   e s t i m a t e d   d a i l y   e x p o s u r e   t o   t h e   f i n i s h e d   p r o d u c t   o f   0 . 9 0   m g / k g / d a y   w a s   o b t a i n e d .   I n   t h e   a b s e n c e   o f   e x a c t   d a t a ,   t h e   d e r m a l   a b s o r p t i o n   w a s   d e t e r m i n e d   i n   l i n e   w i t h   t h e   c r i t e r i a   r e c o m m e n d e d   o n   P a g e   2 8   o f   t h e   S C C S   1 0 t h   G u i d e ,   a c c o r d i n g   t o   w h i c h   a   l e v e l   o f   a b s o r p t i o n   o f   5 0 %   s h o u l d   b e   a s s u m e d .   O n l y   i n   c a s e s   i n   w h i c h   t h e   m o l e c u l a r   w e i g h t   >   5 0 0   D a ,   L o g   P o w   \ u 8 8 0 4 \ ' 3 f - 1   o r   \ u 8 8 0 5 \ ' 3 f 4   a n d   m e l t i n g   p o i n t   >   2 0 0 \ u 1 7 6 \ ' b 0 C   h a s   a   d e r m a l   a b s o r p t i o n   l e v e l   o f   1 0 %   b e e n   a s s u m e d . } \ f 2 \ f s 1 8 \ p a r \ p a r d \ p l a i n \ q l \ s l 2 5 8 \ s l m u l t 1 \ s a 1 6 0 { \ b \ f 2 \ f s 1 8 \ c f 0   - T o x i c o l o g i c a l   P r o f i l e   o f   t h e   S u b s t a n c e s } \ b \ f 2 \ f s 1 8 \ p a r \ p a r d \ p l a i n \ q l \ s l 2 5 8 \ s l m u l t 1 \ s a 1 6 0 { \ f 2 \ f s 1 8 \ c f 0   T h e   t o x i c o l o g i c a l   d a t a   o f   t h e   i n g r e d i e n t s   c o n t a i n e d   i n   t h e   p r o d u c t \ u 8 2 1 7 \ ' 9 2 s   f o r m u l a   a r e   t a k e n   f r o m   t h e   i n f o r m a t i o n   p r o v i d e d   b y   t h e   s u p p l i e r s   o f   t h e   r a w   m a t e r i a l s ,   t h e   d a t a   p u b l i s h e d   i n   t h e   s p e c i a l i s t   l i t e r a t u r e   a n d   t h e   d a t a   a v a i l a b l e   f r o m   r e p o r t s   i s s u e d   b y   t h e   v a r i o u s   i n t e r n a t i o n a l   o r g a n i z a t i o n s   r e s p o n s i b l e   f o r   e v a l u a t i n g   t h e   s a f e t y   o f   d i f f e r e n t   p r o d u c t s ,   s u c h   a s   t h e   S C C S   ( S c i e n t i f i c   C o m m i t t e e   o n   C o n s u m e r   S a f e t y ) ,   t h e   C I R   ( C o s m e t i c   I n g r e d i e n t s   R e v i e w ) ,   t h e   O E C D   ( O r g a n i z a t i o n   f o r   E c o n o m i c   C o - o p e r a t i o n   a n d   D e v e l o p m e n t ) ,   t h e   I U C L I D   ( I n t e r n a t i o n a l   U n i f o r m   C h e m i c a l   I n f o r m a t i o n   D a t a b a s e ) ,   t h e   F D A   ( F o o d   a n d   D r u g   A d m i n i s t r a t i o n ) ,   t h e   U S A   E P A   ( U S   E n v i r o n m e n t a l   P r o t e c t i o n   A g e n c y ) ,   t h e   E F S A   ( E u r o p e a n   F o o d   S a f e t y   A u t h o r i t y )   a n d   t h e   E C H A   ( E u r o p e a n   C h e m i c a l s   A g e n c y ) .   T h e   m a r g i n s   o f   s a f e t y   ( M o S )   w e r e   c a l c u l a t e d   u s i n g   t h e   f o l l o w i n g   f o r m u l a : } \ f 3 \ f s 2 0 \ c f 1 \ p a r } </value>
  </data>
  <data name="xrLabel66.Text" xml:space="preserve">
    <value>Begüm PAZARLI
OZECO GROUP ULUSLARARASI DANIŞMANLIK TİCARET LİMİTED ŞİRKETİ
Şehit Osman Avcı, Malazgirt 1071. Cad. No:49 A İç Kapı No:13, 06820 Eryaman/Ankara 
+90 (850) 308 33 51 / +90 533 450 69 05</value>
  </data>
  <data name="xrLabel62.Text" xml:space="preserve">
    <value>The labelling must comply with the requirements of Article 19 of Regulation (EC) 1223/2009. Any claims made on the packaging must be substantiated with valid data for the formulation which must be kept on file. The finished product label is included in the product information file.</value>
  </data>
  <data name="xrLabel56.Text" xml:space="preserve">
    <value>This report is prepared based on the Regulation (EC) No. 1223/2009 Of The European Parliament and of the Council of 30 November 2009 on cosmetic products and The SCCS's Notes o Guidance for the Testing of Cosmetic Ingredients and Their Safety Evaluation.
Under normal or foreseeable conditions of use, a product made to this formulation is unlikely to produce an abnormally high number of adverse reactions. All the ingredients are well known and have a history of safe use in cosmetics. The composition of the product complies with Article 14 of Regulation (EC) 1223/ 2009.
The undersigned declares that the product is safe under reasonable conditions of use, having evaluated all the data listed above and taking into account the results of all tests performed on the product and experience with similar products.
Following review of the information provided for the above product and its ingredients, the product is considered safe for the intended application and complies with EC Regulation 1223/2009 .
This safety assessment for human health is based upon information available at this date. Reviews of this assessment will be made as and when new information becomes available. In order to ensure that the cosmetic product safety report is kept up to date as required by
Article 10(1)(c) of Regulation (EC) No 1223/2009, the safety of the finished product should be reassessed regularly. The safety assessment should also be reviewed and, if necessary, updated, where one or more of the following circumstances apply:
(a) new scientific findings and toxicological data on the substances are available which could modify the result of the existing safety assessment;
(b) changes occurring in the formulation or specifications of raw materials;
(c) changes occurring in the conditions of use;
(d) a rising trend in terms of the nature, severity and frequency of undesirable effects, both under reasonably foreseeable conditions of use and in the case of misuse.
While preparing the cosmetic product safety report, the toxicological profile of the product components and ingredients, chemical structure, expected interactions (MSDS, allergen list, IFRA certificate, etc.), legal requirements and compliance with the legislation for the product and raw materials, durability data of the product, antimicrobial test data and packaging material. compatibility was evaluated.
Finished product specifications and raw material specifications received from the manufacturer for each raw material were evaluated. The stability of the cosmetic product at different temperatures and its sensitivity to moisture should be evaluated under the tested storage conditions. Storage conditions and duration of the selected study should be sufficient to include storage, transportation and subsequent use. An accelerated stability study was carried out for this product, the durability of the product was tested under two different conditions. The stability test evaluation report is given in the annex of the Product Information File.
In this context, Escherichia coli DSMZ 1576, Pseudomonas aeruginosa DSMZ 1117, Staphylococcus aureus DSMZ 799, Candida albicans ATCC 10231 and Aspergillus niger ATCC 16404 were used. Microbiological test is available in the appendices.
There is no data on impurities and residues.
In the safety assessment for adults, the MoS (safety interval) has been evaluated according to the MoS &gt; 100 in the SCCS directives.
Confidence intervals were calculated for raw materials that could reach NO(A)EL values. The safety of raw materials whose.
NO(A)ELvalues are not reached has been evaluated as safe by examining CIR, COSING and literature. The confidence inte rval for all the calculated raw materials was found to be greater than 100. It is safe to use raw materials at this concentration for this product as well. By taking the upper limit usage rate of the raw materials and assuming 100% absorbtion, the worst-possible safety interval was calculated.
It has been seen that the information of the manufacturer and the responsible company on the finished product label, all the raw materials in the list of product components on the label, are written with the names of INCI and in order from largest to smallest according to the % concentration. Necessary symbols are included. The label has been observed to comply with the legislation.
The components in the product are the raw materials that are allowed to be used in cosmetics and are suitable for use. All raw materials are non-toxic at these concentrations when used under normal and predictable conditions. The product does not include the substances in the list of prohibited substances in the Regulation on the Amendment of the Cosmetic Regulation and the Annexes of the Regulation. The product composition complies with the cosmetic legislation. No undesirable effects or serious undesirable effects were reported.
This report has been prepared in line with the available data. The content of the product, the stability data, should be revised when there is a change in the packaging material.
Since the product has passed the laboratory tests and the MoS values of the raw materials are safe, the product is suitable for normal and reasonably foreseeable use under normal conditions, according to the place of use, purpose and amount of use.</value>
  </data>
  <data name="xrRichText1.SerializableRtfString" xml:space="preserve">
    <value>ewBcAHIAdABmADEAXABkAGUAZgBmADAAewBcAGYAbwBuAHQAdABiAGwAewBcAGYAMAAgAEMAYQBsAGkAYgByAGkAOwB9AHsAXABmADEAXABmAGMAaABhAHIAcwBlAHQAMQA2ADIAIABUAGkAbQBlAHMAIABOAGUAdwAgAFIAbwBtAGEAbgA7AH0AewBcAGYAMgBcAGYAYwBoAGEAcgBzAGUAdAAxADYAMgAgAEYAdQB0AHUAcgBhACAAQgBrACAAQgBUADsAfQB9AHsAXABjAG8AbABvAHIAdABiAGwAIAA7AFwAcgBlAGQAMABcAGcAcgBlAGUAbgAwAFwAYgBsAHUAZQAwACAAOwBcAHIAZQBkADAAXABnAHIAZQBlAG4AMABcAGIAbAB1AGUAMgA1ADUAIAA7AH0AewBcACoAXABkAGUAZgBjAGgAcAAgAFwAZgAxAFwAZgBzADIANAB9AHsAXABzAHQAeQBsAGUAcwBoAGUAZQB0ACAAewBcAHEAbABcAGYAMQBcAGYAcwAyADQAIABOAG8AcgBtAGEAbAA7AH0AewBcACoAXABjAHMAMQBcAGYAMQBcAGYAcwAyADQAXABjAGYAMQAgAEQAZQBmAGEAdQBsAHQAIABQAGEAcgBhAGcAcgBhAHAAaAAgAEYAbwBuAHQAOwB9AHsAXAAqAFwAYwBzADIAXABzAGIAYQBzAGUAZABvAG4AMQBcAGYAMQBcAGYAcwAyADQAXABjAGYAMQAgAEwAaQBuAGUAIABOAHUAbQBiAGUAcgA7AH0AewBcACoAXABjAHMAMwBcAHUAbABcAGYAMQBcAGYAcwAyADQAXABjAGYAMgAgAEgAeQBwAGUAcgBsAGkAbgBrADsAfQB7AFwAKgBcAHQAcwA0AFwAdABzAHIAbwB3AGQAXABmADEAXABmAHMAMgA0AFwAcQBsAFwAdABzAGMAZQBsAGwAcABhAGQAZABmAGwAMwBcAHQAcwBjAGUAbABsAHAAYQBkAGQAbAAxADAAOABcAHQAcwBjAGUAbABsAHAAYQBkAGQAZgBiADMAXAB0AHMAYwBlAGwAbABwAGEAZABkAGYAcgAzAFwAdABzAGMAZQBsAGwAcABhAGQAZAByADEAMAA4AFwAdABzAGMAZQBsAGwAcABhAGQAZABmAHQAMwBcAHQAcwB2AGUAcgB0AGEAbAB0AFwAYwBsAHQAeABsAHIAdABiACAATgBvAHIAbQBhAGwAIABUAGEAYgBsAGUAOwB9AHsAXAAqAFwAdABzADUAXAB0AHMAcgBvAHcAZABcAHMAYgBhAHMAZQBkAG8AbgA0AFwAZgAxAFwAZgBzADIANABcAHEAbABcAHQAcgBiAHIAZAByAHQAXABiAHIAZAByAHMAXABiAHIAZAByAHcAMQAwAFwAdAByAGIAcgBkAHIAbABcAGIAcgBkAHIAcwBcAGIAcgBkAHIAdwAxADAAXAB0AHIAYgByAGQAcgBiAFwAYgByAGQAcgBzAFwAYgByAGQAcgB3ADEAMABcAHQAcgBiAHIAZAByAHIAXABiAHIAZAByAHMAXABiAHIAZAByAHcAMQAwAFwAdAByAGIAcgBkAHIAaABcAGIAcgBkAHIAcwBcAGIAcgBkAHIAdwAxADAAXAB0AHIAYgByAGQAcgB2AFwAYgByAGQAcgBzAFwAYgByAGQAcgB3ADEAMABcAHQAcwBjAGUAbABsAHAAYQBkAGQAZgBsADMAXAB0AHMAYwBlAGwAbABwAGEAZABkAGwAMQAwADgAXAB0AHMAYwBlAGwAbABwAGEAZABkAGYAcgAzAFwAdABzAGMAZQBsAGwAcABhAGQAZAByADEAMAA4AFwAdABzAHYAZQByAHQAYQBsAHQAXABjAGwAdAB4AGwAcgB0AGIAIABUAGEAYgBsAGUAIABTAGkAbQBwAGwAZQAgADEAOwB9AH0AewBcACoAXABsAGkAcwB0AG8AdgBlAHIAcgBpAGQAZQB0AGEAYgBsAGUAfQBcAG4AbwB1AGkAYwBvAG0AcABhAHQAXABzAHAAbAB5AHQAdwBuAGkAbgBlAFwAaAB0AG0AYQB1AHQAcwBwAFwAYQBsAG4AdABiAGwAaQBuAGQAXABlAHgAcABzAGgAcgB0AG4AXABzAHAAbAB0AHAAZwBwAGEAcgBcAG4AbwBnAHIAbwB3AGEAdQB0AG8AZgBpAHQAXABwAGEAcgBkAFwAcABsAGEAaQBuAFwAcQBsAFwAcwBsADIANQA4AFwAcwBsAG0AdQBsAHQAMQBcAHMAYQAxADYAMAB7AFwAYgBcAGYAMgBcAGYAcwAxADgAXABjAGYAMAAgAFAAQQBSAFQAIABBACAALQAgAEMATwBTAE0ARQBUAEkAQwAgAFAAUgBPAEQAVQBDAFQAIABTAEEARgBFAFQAWQAgAEkATgBGAE8AUgBNAEEAVABJAE8ATgB9AFwAYgBcAGYAMgBcAGYAcwAxADgAXABwAGEAcgBcAHAAYQByAGQAXABwAGwAYQBpAG4AXABxAGwAXABzAGwAMgA1ADgAXABzAGwAbQB1AGwAdAAxAFwAcwBhADEANgAwAHsAXABmADIAXABmAHMAMQA4AFwAYwBmADAAIABBAC4AMQAuACAAUQB1AGEAbgB0AGkAdABhAHQAaQB2AGUAIABhAG4AZAAgAHEAdQBhAGwAaQB0AGEAdABpAHYAZQAgAGMAbwBtAHAAbwBzAGkAdABpAG8AbgAgAG8AZgAgAHQAaABlACAAYwBvAHMAbQBlAHQAaQBjACAAcAByAG8AZAB1AGMAdABcAGwAaQBuAGUAIABBAC4AMgAuACAAUABoAHkAcwBpAGMAYQBsAC8AYwBoAGUAbQBpAGMAYQBsACAAYwBoAGEAcgBhAGMAdABlAHIAaQBzAHQAaQBjAHMAIABhAG4AZAAgAHMAdABhAGIAaQBsAGkAdAB5ACAAbwBmACAAdABoAGUAIABjAG8AcwBtAGUAdABpAGMAIABwAHIAbwBkAHUAYwB0AFwAbABpAG4AZQAgAGEALgAgAFAAaAB5AHMAaQBjAGEAbAAvAGMAaABlAG0AaQBjAGEAbAAgAGMAaABhAHIAYQBjAHQAZQByAGkAcwB0AGkAYwBzACAAbwBmACAAcwB1AGIAcwB0AGEAbgBjAGUAcwAgAG8AcgAgAG0AaQB4AHQAdQByAGUAcwBcAGwAaQBuAGUAIABiAC4AIABQAGgAeQBzAGkAYwBhAGwALwBjAGgAZQBtAGkAYwBhAGwAIABjAGgAYQByAGEAYwB0AGUAcgBpAHMAdABpAGMAcwAgAG8AZgAgAHQAaABlACAAYwBvAHMAbQBlAHQAaQBjACAAcAByAG8AZAB1AGMAdABcAGwAaQBuAGUAIABjAC4AIABTAHQAYQBiAGkAbABpAHQAeQAgAG8AZgAgAHQAaABlACAAYwBvAHMAbQBlAHQAaQBjACAAcAByAG8AZAB1AGMAdABcAGwAaQBuAGUAIAAoADEAKQAgAEUAdgBpAGQAZQBuAGMAZQAgAHQAaABhAHQAIAB0AGgAZQAgAGMAbwBtAHAAbwBzAGkAdABpAG8AbgAgAG8AZgAgAHQAaABlACAAcAByAG8AZAB1AGMAdAAgAHUAcwBlAGQAIABmAG8AcgAgAHMAdABhAGIAaQBsAGkAdAB5ACAAdABlAHMAdABpAG4AZwAgAGMAbwByAHIAZQBzAHAAbwBuAGQAcwAgAHQAbwAgAHQAaABlACAAcAByAG8AZAB1AGMAdAAgAGEAYwB0AHUAYQBsAGwAeQAgAHAAbABhAGMAZQBkACAAbwBuACAAdABoAGUAIABtAGEAcgBrAGUAdABcAGwAaQBuAGUAIAAoADIAKQAgAFQAaABlACAAcgBlAHMAdQBsAHQAcwAgAG8AZgAgAHQAaABlACAAcAByAGUAcwBlAHIAdgBhAHQAaQB2AGUAIABlAGYAZgBpAGMAYQBjAHkAIABzAHQAdQBkAHkALAAgAEMAaABhAGwAbABlAG4AZwBlACAAVABlAHMAdABcAGwAaQBuAGUAIAAoADMAKQAgAFQAaABlACAAcABlAHIAaQBvAGQALQBhAGYAdABlAHIALQBvAHAAZQBuAGkAbgBnACAAKABQAEEATwApACAAYQBuAGQAIABpAHQAcwAgAGoAdQBzAHQAaQBmAGkAYwBhAHQAaQBvAG4AXABsAGkAbgBlACAAQQAuADMALgAgAE0AaQBjAHIAbwBiAGkAbwBsAG8AZwBpAGMAYQBsACAAcQB1AGEAbABpAHQAeQBcAGwAaQBuAGUAIABhAC4AIABNAGkAYwByAG8AYgBpAG8AbABvAGcAaQBjAGEAbAAgAHEAdQBhAGwAaQB0AHkAIABvAGYAIABzAHUAYgBzAHQAYQBuAGMAZQBzACAAYQBuAGQAIABtAGkAeAB0AHUAcgBlAHMAXABsAGkAbgBlACAAYgAuACAATQBpAGMAcgBvAGIAaQBvAGwAbwBnAGkAYwBhAGwAIABxAHUAYQBsAGkAdAB5ACAAbwBmACAAdABoAGUAIABmAGkAbgBpAHMAaABlAGQAIABjAG8AcwBtAGUAdABpAGMAIABwAHIAbwBkAHUAYwB0AFwAbABpAG4AZQAgAEEALgA0AC4AIABJAG0AcAB1AHIAaQB0AGkAZQBzACwAIAB0AHIAYQBjAGUAcwAsACAAaQBuAGYAbwByAG0AYQB0AGkAbwBuACAAYQBiAG8AdQB0ACAAdABoAGUAIABwAGEAYwBrAGEAZwBpAG4AZwAgAG0AYQB0AGUAcgBpAGEAbABcAGwAaQBuAGUAIABhAC4AIABQAHUAcgBpAHQAeQAgAG8AZgAgAHMAdQBiAHMAdABhAG4AYwBlAHMAIABhAG4AZAAgAG0AaQB4AHQAdQByAGUAcwBcAGwAaQBuAGUAIABiAC4AIABFAHYAaQBkAGUAbgBjAGUAIABvAGYAIAB0AGgAZQAgAHQAZQBjAGgAbgBpAGMAYQBsACAAdQBuAGEAdgBvAGkAZABhAGIAaQBsAGkAdAB5ACAAbwBmACAAdAByAGEAYwBlAHMAIABvAGYAIABwAHIAbwBoAGkAYgBpAHQAZQBkACAAcwB1AGIAcwB0AGEAbgBjAGUAcwBcAGwAaQBuAGUAIABjAC4AIABUAGgAZQAgAHIAZQBsAGUAdgBhAG4AdAAgAGMAaABhAHIAYQBjAHQAZQByAGkAcwB0AGkAYwBzACAAbwBmACAAcABhAGMAawBhAGcAaQBuAGcAIABtAGEAdABlAHIAaQBhAGwAXABsAGkAbgBlACAAQQAuADUALgAgAE4AbwByAG0AYQBsACAAYQBuAGQAIAByAGUAYQBzAG8AbgBhAGIAbAB5ACAAZgBvAHIAZQBzAGUAZQBhAGIAbABlACAAdQBzAGUAXABsAGkAbgBlACAAQQAuADYALgAgAEUAeABwAG8AcwB1AHIAZQAgAHQAbwAgAHQAaABlACAAYwBvAHMAbQBlAHQAaQBjACAAcAByAG8AZAB1AGMAdABcAGwAaQBuAGUAIABBAC4ANwAuACAARQB4AHAAbwBzAHUAcgBlACAAdABvACAAdABoAGUAIABzAHUAYgBzAHQAYQBuAGMAZQBzAFwAbABpAG4AZQAgAEEALgA4AC4AIABUAG8AeABpAGMAbwBsAG8AZwBpAGMAYQBsACAAcAByAG8AZgBpAGwAZQAgAG8AZgAgAHQAaABlACAAcwB1AGIAcwB0AGEAbgBjAGUAcwBcAGwAaQBuAGUAIABhAC4AIABUAG8AeABpAGMAbwBsAG8AZwBpAGMAYQBsACAAUAByAG8AZgBpAGwAZQAgAG8AZgAgAFQAaABlACAAUwB1AGIAcwB0AGEAbgBjAGUAcwBcAGwAaQBuAGUAIABiAC4AIABDAG8AbgBzAGkAZABlAHIAYQB0AGkAbwBuACAAbwBmACAAcwB5AHMAdABlAG0AaQBjACAAZQBmAGYAZQBjAHQAcwAgAGEAbgBkACAAYwBhAGwAYwB1AGwAYQB0AGkAbwBuACAAbwBmACAAdABoAGUAIABtAGEAcgBnAGkAbgAgAG8AZgAgAHMAYQBmAGUAdAB5AFwAbABpAG4AZQAgAGMALgAgAEMAbwBuAHQAcgBvAGwAIABvAGYAIAB0AGgAZQAgAFMAdQBiAHMAdABhAG4AYwBlAHMAXAB1ADgAMgAxADcAXAAnADkAMgAgAEMAbwBtAHAAbABpAGEAbgBjAGUAIAB3AGkAdABoACAAdABoAGUAIABSAGUAZwB1AGwAYQB0AGkAbwBuACAAKABFAGMAKQAgAE4AbwAgADEAMgAyADMALwAyADAAMAA5AFwAbABpAG4AZQAgAEEALgA5AC4AIABVAG4AZABlAHMAaQByAGEAYgBsAGUAIABlAGYAZgBlAGMAdABzACAAYQBuAGQAIABzAGUAcgBpAG8AdQBzACAAdQBuAGQAZQBzAGkAcgBhAGIAbABlACAAZQBmAGYAZQBjAHQAcwBcAGwAaQBuAGUAIABBAC4AMQAwAC4AIABJAG4AZgBvAHIAbQBhAHQAaQBvAG4AIABvAG4AIAB0AGgAZQAgAGMAbwBzAG0AZQB0AGkAYwAgAHAAcgBvAGQAdQBjAHQAfQBcAGYAMgBcAGYAcwAxADgAXABwAGEAcgBcAHAAYQByAGQAXABwAGwAYQBpAG4AXABxAGwAXABzAGwAMgA1ADgAXABzAGwAbQB1AGwAdAAxAFwAcwBhADEANgAwAHsAXABiAFwAZgAyAFwAZgBzADEAOABcAGMAZgAwACAAUABBAFIAVAAgAEIAIAAtACAAQwBPAFMATQBFAFQASQBDACAAUABSAE8ARABVAEMAVAAgAFMAQQBGAEUAVABZACAAQQBTAFMARQBTAFMATQBFAE4AVAB9AFwAYgBcAGYAMgBcAGYAcwAxADgAXABwAGEAcgBcAHAAYQByAGQAXABwAGwAYQBpAG4AXABxAGwAXABzAGwAMgA1ADgAXABzAGwAbQB1AGwAdAAxAFwAcwBhADEANgAwAHsAXABmADIAXABmAHMAMQA4AFwAYwBmADAAIABCAC4AMQAuACAAQQBzAHMAZQBzAHMAbQBlAG4AdAAgAGMAbwBuAGMAbAB1AHMAaQBvAG4AXABsAGkAbgBlACAAQgAuADIALgAgAEwAYQBiAGUAbABsAGUAZAAgAHcAYQByAG4AaQBuAGcAcwAgAGEAbgBkACAAaQBuAHMAdAByAHUAYwB0AGkAbwBuAHMAIABvAGYAIAB1AHMAZQBcAGwAaQBuAGUAIABCAC4AMwAuACAAUgBlAGEAcwBvAG4AaQBuAGcAXABsAGkAbgBlACAAQgAuADQALgAgAEEAcwBzAGUAcwBzAG8AcgBcAHUAOAAyADEANwBcACcAOQAyAHMAIABjAHIAZQBkAGUAbgB0AGkAYQBsAHMAIABhAG4AZAAgAGEAcABwAHIAbwB2AGEAbAAgAG8AZgAgAFAAYQByAHQAIABCAH0AXABmADEAXABmAHMAMgA0AFwAYwBmADEAXABwAGEAcgB9AA==</value>
  </data>
  <data name="xrLabel76.Text" xml:space="preserve">
    <value>The test involves the preparation of appropriate microorganisms at specific inoculum levels and the enumeration of microorganisms in the sample by inoculating the sample containing microorganisms at specific time intervals. The adequacy of the preservative properties of the product is determined by determining whether a significant decrease or increase in microorganisms is observed at 7, 14 and 28 days under the test conditions.
According to the test results, the manufacturer guarantees the efficacy of the preservation of this product experimentially by carrying out challenge test.
See Annex - Challenge Test Report</value>
  </data>
  <data name="xrLabel74.Text" xml:space="preserve">
    <value>The SCCS has recommended that relevant stability tests, adapted to the type of cosmetic product and its intended use, should be carried out. The manufacturer guarantied that stability tests are currently carried out with inert containers and those intended to be used on the market by declaration.</value>
  </data>
</root>